Gemphire is a clinical-stage biopharmaceutical company that is dedicated to finding new ways to treat patients suffering from cardiometabolic disorders. Their main focus is on developing a product candidate called gemcabene, which can be used in combination with standard treatments like statins to provide more effective relief. Their goal is to provide convenient and cost-effective treatment options for a wider range of patients, while also benefiting physicians and payors.